September 8, 2025
Envol Biomedical is proud to share that Dr. Reinier Espinosa, Director of Translational Science and Surgical Services, will be attending the 41st Annual Meeting of the Academy of Surgical Research, taking place September 17–19, 2025, in Minneapolis, MN.
This premier event brings together leaders in surgical innovation, advancing techniques, and translational research. With a strong emphasis on hands-on training and the exchange of knowledge, it’s an ideal forum for showcasing Envol’s growing capabilities in complex surgical procedures and advanced delivery methods.
Why The ASR Meeting Matters
The Academy of Surgical Research Annual Meeting is recognized for its focus on cutting-edge surgical procedures, new technologies, and practical lab demonstrations. Attendees gain firsthand experience in workshops and wet labs, where novel approaches to surgical challenges are shared, tested, and refined.
For Envol, the timing couldn’t be better. Over the past two years, our surgical department has expanded significantly, building expertise in CNS delivery techniques, endovascular dosing, and complex survival surgeries. Participation in this meeting underscores our commitment to advancing surgical science and deepening collaborations with peers across the field.
What Dr Espinosa Will Be Sharing
During the meeting, Dr. Espinosa looks forward to discussing Envol’s latest advancements, including:
- CNS-Guided Delivery with Breakthrough Accuracy
Envol’s team has achieved improvements in guided CNS dosing accuracy, climbing from 75% to over 95%. This leap reflects not only technical innovation but also our in-depth understanding of nonhuman primate physiology and anatomy. - Complex Surgical Capabilities
Envol is among the few organizations worldwide capable of conducting kidney transplants, advanced device implantations (micro and macro), and long-term survival studies. These capabilities make us a unique partner for translational research programs requiring high-complexity procedures. - Expanding Surgical Knowledge
As Dr. Espinosa highlights, the meeting is an opportunity not just to present but also to learn. By engaging with global experts, Envol strengthens its capacity to deliver precise, reliable results to clients tackling their most challenging research needs.
What Attendees Should Know About Envol Biomedical
Envol Biomedical is a trusted partner for GLP toxicology, pharmacology, and surgical services. With vertically integrated resources—including in-house nonhuman primate supply, advanced surgical expertise, and cross-disciplinary research capabilities—Envol supports sponsors with reliable, high-quality preclinical solutions.
- Envol is the largest provider of nonhuman primate models in North America, giving sponsors access to resources unmatched in scale and reliability.
- Our surgical team, led by board-certified MD specialists, brings deep expertise across neurosurgery, intensive care, and translational medicine.
- We combine technical excellence with a client-focused approach, providing clear communication and dependable data to accelerate discovery and development.
Connect with Reinier in Minneapolis
Dr. Espinosa will be attending sessions, wet labs, and networking events throughout the three-day meeting. While Envol will not be hosting a booth this year, Reinier welcomes the opportunity to meet colleagues, share experiences, and discuss new opportunities for collaboration. If you’re attending the Academy of Surgical Research Annual Meeting, be sure to connect with Reinier and learn more about how Envol Biomedical is driving innovation in surgical science.